Stockreport

Ipsen and Skyhawk Therapeutics announce RNA targeting research collaboration in rare neurological diseases

IPSEN SA S/ADR  (IPSEY) 
NASDAQ:AMEX Investor Relations: ipsen.com/investors
PDF Ipsen enters into an option agreement to receive exclusive global rights to two candidates pursued under the collaborationFollowing development candidate validation, Ips [Read more]